Page 5 - Settlement Regulations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Settlement regulations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Settlement Regulations Today - Breaking & Trending Today

SEBI Disposes Of Adjudication Proceedings Against Three Entities, One Individual After Settlement


SEBI disposes of adjudication proceedings against three entities, one individual after settlement
As per two separate orders passed on Thursday, it was alleged that the entities had indulged in non-genuine trades and created a false and misleading appearance of trading in the stock options segment of BSE.
PTI
SEBI headquarters
SEBI has disposed of adjudication proceedings against three entities and an individual after they settled cases related to alleged fraudulent trading activities in illiquid stock options segment on BSE.
The individual Harish Kumar and Aryav Securities Pvt Ltd have settled the case.
As per two separate orders passed on Thursday, it was alleged that the entities had indulged in non-genuine trades and created a false and misleading appearance of trading in the stock options segment of BSE. ....

Jammu And Kashmir , Harish Kumar , Consulting Ltd , Kundan Care Products Ltd , Aryav Securities Pvt Ltd , Unfair Trade Practices , Settlement Scheme , Settlement Regulations , Aryav Securities , Care Products Ltd , Kundan Care Products , Market News , ஜம்மு மற்றும் காஷ்மீர் , கடுமையான குமார் , ஆலோசனை லிமிடெட் , குண்டன் பராமரிப்பு ப்ராடக்ட்ஸ் லிமிடெட் , நியாயமற்றது வர்த்தகம் ப்ர்யாக்டிஸஸ் , தீர்வு திட்டம் , தீர்வு ஒழுங்குமுறைகள் , பராமரிப்பு ப்ராடக்ட்ஸ் லிமிடெட் , குண்டன் பராமரிப்பு ப்ராடக்ட்ஸ் , சந்தை செய்தி ,

Sun Pharmaceutical Industries Ltd settles whistleblower complaint with Sebi


Sun Pharmaceutical Industries Ltd and its founder Dilip Shanghvi have settled a whistleblower complaint with the Securities and Exchange Board of India (Sebi) alleging diversion of funds through the company’s sole distributor.
Sun Pharma has paid a settlement amount of Rs 56.1 lakh, Shanghvi has paid Rs 62.35 lakh. 
Other top executives of the company that included chief financial officer- Uday Baldota (Rs 24.65 lakh), whole time directors Kalyanasundaram Subramanian (Rs 36.9 lakh), Sailesh T. Desai (Rs 37.41 lakh) and Sudhir V. Valia (Rs 37.41 lakh) have also settled the case without admission or denial of guilt before the capital market regulator.
Whistleblower complaints were made against the country’s largest drug maker and its wholly owned subsidiary, Sun Pharmaceutical Laboratories Ltd, alleging that they had been diverting funds through Aditya Medisales Ltd (AML), its sole distributor in India. It was also alleged that transactions with AML were going on fo ....

Sun Pharma , Sailesht Desai , Dilip Shanghvi , Sudhirv Valia , Aditya Medisales Ltd , Exchange Board Of India Sebi , Sun Pharmaceutical Industries Ltd , Sun Pharmaceutical Laboratories Ltd , Exchange Board , Kalyanasundaram Subramanian , Listing Obligation , Disclosure Requirements , Annual Reports , Settlement Regulations , சூரியன் பார்மா , நீர்த்துப்போக ஷாங்க்வி , பரிமாற்றம் பலகை ஆஃப் இந்தியா செபி , சூரியன் மருந்து தொழில்கள் லிமிடெட் , சூரியன் மருந்து ஆய்வகங்கள் லிமிடெட் , பரிமாற்றம் பலகை , கல்யாணசுந்தரம் சுப்ரமணியன் , வெளிப்படுத்தல் தேவைகள் , ஆண்டு அறிக்கைகள் , தீர்வு ஒழுங்குமுறைகள் ,